Expert Network
Scientific Advisory Board
The Helixgate Scientific Advisory Board brings together researchers, technologists, and industry experts who provide perspective on emerging biotechnology and life‑science innovation. Members of the advisory board contribute insights on scientific developments, research trends, and emerging technologies that are shaping the future of biotechnology.
Dr. Catherine Wei
Director of Computational Biology
Stanford University
Dr. Wei leads Stanford’s computational biology division, specializing in machine learning applications for genomics and precision medicine.
Prof. Henrik Larsson
Chair of Synthetic Biology
ETH Zurich
Prof. Larsson is a pioneer in synthetic biology and metabolic engineering, with a focus on cell factory design for sustainable biomanufacturing.
Dr. Amara Osei
VP of Research
Genentech
Dr. Osei oversees computational drug discovery programs at Genentech, integrating AI and structural biology for novel therapeutic development.
Prof. David Nakamura
Chair of Bioengineering
UC Berkeley
Prof. Nakamura is a leading figure in CRISPR technology development and genome engineering, with over 200 peer-reviewed publications.
Dr. Maria Fernandez
Chief Scientific Officer
Twist Bioscience
Dr. Fernandez leads scientific strategy at Twist Bioscience, driving innovation in synthetic biology and next-generation sequencing technologies.
Prof. Robert Ashford
Director of Drug Discovery
University of Cambridge
Prof. Ashford specializes in structure-based drug design and has contributed to multiple approved therapeutics over a distinguished career.